Table 1. Demographic and clinicopathological characteristics of 19 OCS patients.
| Demographic and Pathologic Features | N | Death (%) | P-Value |
|---|---|---|---|
| Age at diagnosis | |||
| Median (range) | 58 (32–75) | NA | |
| Mean (SD) | 58.5 (11.1) | ||
| Family history of malignancy | 0.607 | ||
| Y | 14 | 7 (50.0) | |
| N | 5 | 4 (80.0) | |
| FIGO stage | 0.153 | ||
| I | 2 | 0 (0.0) | |
| II | 5 | 2 (40.0) | |
| III | 12 | 9 (75.0) | |
| Menopause | |||
| Y | 15 | 9 (60.0) | 0.996 |
| N | 4 | 2 (50.0) | |
| BMI | 0.438 | ||
| < 25 | 10 | 5 (50.0) | |
| ≥ 25 | 9 | 6 (66.7) | |
| Pretreatment CA-125 | 0.948 | ||
| ≤ 200 U/ml | 4 | 2 (50.0) | |
| > 200 U/ml | 14 | 9 (64.3) | |
| Ascitic fluid | 0.089 | ||
| Negative | 9 | 6 (66.7) | |
| Positive | 10 | 5 (50.0) | |
| Bilateral tumors | 0.027 | ||
| N | 14 | 6 (42.9) | |
| Y | 5 | 5 (100.0) | |
| Tumor size, cm | 0.286 | ||
| ≤ 12 | 11 | 7 (63.6) | |
| > 12 | 8 | 4 (50.0) | |
| Mesenchymal component | 0.111 | ||
| Homologous | 9 | 5 (55.6) | |
| Heterologous | 10 | 6 (60.0) | |
| Residual disease | 0.019 | ||
| NVD | 6 | 2 (33.3) | |
| ≤ 1cm | 6 | 2 (33.3) | |
| > 1cm | 7 | 7 (100.0) | |
| Adjuvant chemotherapy | 0.367 | ||
| Y | 16 | 8 (50.0) | |
| N | 3 | 3 (100.0) |
NVD = no visible disease.